Abstract
In 2007, the European Task Force for neuronopathic Gaucher disease (NGD) published a review of 55 patients across four countries. Although some observations were possible, analysis was difficult due to the absence of a systematic way of assessing patients. In response to this, a Severity Scoring Tool (SST) was devised to offer a systematic means of assessing the neurological presentation seen. The SST has been modified (mSST) and is a valid tool for monitoring neurological progression. This review describes disease status and progression of neurological manifestations in a cohort of 39 chronic NGD patients across three European countries over a period of 4 years, using the mSST.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Davies E, Erikson A, Collin-Histed T, Mengel E, Tylki-Szymanska A, Vellodi A (2007a) Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases. J Inherit Metab Dis 30(6):935–42
Davies E, Surtees R, DeVile C, Schoon I, Vellodi A (2007b) A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease. J Inherit Metab Dis 30(5):768–82. 5, Epub 2007 Sep 16
Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik I, Timmons M, Ries M, Vellodi A (2008) A randomized controlled trial of miglustat in Gaucher disease type 3. Ann Neurol 64(5):514–22
Tylki-Szymańska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E (2010) Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis 33(4):339–46
Vellodi A, Bembi B, de Villemeur TB, Collin-Histed T, Erikson A, Mengel E, Rolfs A, Tylki-Szymanska A (2001) Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease. 2001 Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 24(3):319–27
Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, Mengel E, Erikson A, Schiffmann R (2009) Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 32(5):660–4, Aug 5
Acknowledgement
This work was made possible by grants from the Gaucher Association UK and Genzyme. Thank you also to the international experts who took part in the discussion to modify the SST: Amal El Beshlawy, Egypt; B. Bembi, Italy; Edward Giannini, USA; Thong Meow Keong, Malaysia; Ana Maria Martins, Brazil; A Tylki-Szymanska, Poland; Ashok Vellodi, UK.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Gregory M. Pastores
Competing interest: None declared
Rights and permissions
About this article
Cite this article
Davies, E.H., Mengel, E., Tylki-Szymanska, A. et al. Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool. J Inherit Metab Dis 34, 1053–1059 (2011). https://doi.org/10.1007/s10545-011-9347-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-011-9347-z